Skip to main content

. 1962 Mar 17;1(5280):747–753. doi: 10.1136/bmj.1.5280.747

Small-scale Trial with Sabin Attenuated Type 1 Poliovirus Vaccine in a Semi-closed Community^*

J M Hoskins, D Hobson, V Udall, Tora Madland, A P Goffe, C H Stuart-Harris, E G Herzog

PMCID: PMC1957909 PMID: 14449180

747

Images in this article

Fig. 3
on p.751

Fig. 4
on p.752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BODIAN D., MORGAN I. M., SCHWERDT C. E. Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice. Am J Hyg. 1950 Jan;51(1):126-33, illust. doi: 10.1093/oxfordjournals.aje.a119373. [DOI] [PubMed] [Google Scholar]
CLARKE S. K., GOFFE A. P., STUART-HARRIS C. H., HERZOG E. G. A small-scale trial of type III attenuated living poliovirus vaccine. Br Med J. 1958 Nov 15;2(5106):1188–1193. doi: 10.1136/bmj.2.5106.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
COOPER P. D. A method for producing plaques in agar suspensions of animal cells. Virology. 1955 Nov;1(4):397–401. doi: 10.1016/0042-6822(55)90033-7. [DOI] [PubMed] [Google Scholar]
HOSKINS J. M. Host-controlled variation in animal viruses. Bull Schweiz Akad Med Wiss. 1960 Oct;16:141–154. [PubMed] [Google Scholar]
HSIUNG G. D. Studies on variation in Coxsackie A-9 virus. J Immunol. 1960 Mar;84:285–291. [PubMed] [Google Scholar]
KANDA Y., MELNICK J. L. In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J Exp Med. 1959 Jan 1;109(1):9–24. doi: 10.1084/jem.109.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
LWOFF A., LWOFF M. Remarques sur quelques caractères du développment du virus de la poliomyélite. C R Hebd Seances Acad Sci. 1959 Mar 16;248(11):1725–1727. [PubMed] [Google Scholar]
MORGAN J. F., MORTON H. J., PARKER R. C. Nutrition of animal cells in tissue culture; initial studies on a synthetic medium. Proc Soc Exp Biol Med. 1950 Jan;73(1):1–8. doi: 10.3181/00379727-73-17557. [DOI] [PubMed] [Google Scholar]
PERKINS F. T., EVANS D. G. British standard poliomyelitis antisera types 1, 2, and 3. Br Med J. 1959 Jun 20;1(5137):1549–1553. doi: 10.1136/bmj.1.5137.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
SABIN A. B. Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc. 1956 Dec 29;162(18):1589–1596. doi: 10.1001/jama.1956.02970350005002. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES